ALNYLAM PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
49 Contracts & Agreements
- Credit Agreements (2 contracts)
- Exchange Agreements (2)
- Indenture Agreements (2)
- Investment Agreements (1)
- Investor Rights Agreements (2)
- Loan Agreements (2)
- Purchase Agreements (3)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (23)
- Underwriting Agreements (9)
- Warrant Agreements (1)
- Amendment to Purchase and Sale Agreement dated October 31, 2022 between BX Bodyguard Royalties L.P. and the Registrant (Filed With SEC on February 23, 2023)
- Indenture, dated as of September 15, 2022, between the Registrant (Filed With SEC on October 27, 2022)
- Indenture, dated as of September 15, 2022, between Alnylam Pharmaceuticals, Inc. and The Bank of New York Mellon, as trustee (Filed With SEC on September 16, 2022)
- Amendment No. 1 to Co-Development Agreement between the Registrant and BXLS V Bodyguard PCP L.P. and BXLS Family Investment Partnership V ESC L.P. dated November 23, 2021 (Filed With SEC on February 10, 2022)
- Purchase and Sale Agreement dated April 10, 2020 between BX Bodyguard Royalties L.P. and the Registrant (Filed With SEC on August 6, 2020)
- Description of Capital Stock (Filed With SEC on February 13, 2020)
- Stock Purchase Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
- Amended and Restated 2004 Employee Stock Purchase Plan, as amended (Filed With SEC on May 2, 2019)
- Underwriting Agreement, dated January 14, 2019, between Alnylam Pharmaceuticals, Inc. and Barclays Capital Inc (Filed With SEC on January 15, 2019)
- Underwriting Agreement, dated November 13, 2017, by and among Alnylam Pharmaceuticals, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the... (Filed With SEC on November 14, 2017)
- ALNYLAM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2004 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 9, 2017)
- ALNYLAMPHARMACEUTICALS, INC. 5,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 25, 2017)
- ALNYLAM PHARMACEUTICALS, INC. Form of Nonstatutory Stock OptionAgreement Non-Plan Inducement Grant (Filed With SEC on November 3, 2016)
- CREDIT AGREEMENT Dated asof April 29, 2016 Among ALNYLAM U.S., INC., as the Borrower, ALNYLAMPHARMACEUTICALS, INC., as Parent and Parent Guarantor, and WELLS FARGO BANK,NATIONAL... (Filed With SEC on August 4, 2016)
- CREDIT AGREEMENT Dated asof April 29, 2016 Among ALNYLAM U.S., INC., as theBorrower, ALNYLAM PHARMACEUTICALS, INC., as Parent and Parent Guarantor, and BANK OF AMERICA,N.A., as... (Filed With SEC on August 4, 2016)
- PURCHASE AND SALE AGREEMENT (Filed With SEC on May 4, 2016)
- ALNYLAM PHARMACEUTICALS, INC. Restricted Stock Agreement (Filed With SEC on August 7, 2015)
- CERTIFICATE OF ELIMINATION OF THE SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF ALNYLAM PHARMACEUTICALS, INC. Pursuant to Section 151(g) of the General Corporation Law ofthe... (Filed With SEC on July 14, 2015)
- ALNYLAMPHARMACEUTICALS, INC. 4,736,842 Shares of Common Stock Underwriting Agreement (Filed With SEC on January 26, 2015)
- ALNYLAM PHARMACEUTICALS, INC. Restricted Stock Agreement (Filed With SEC on August 8, 2014)
- STOCK PURCHASE AGREEMENT By and Between GENZYMECORPORATION AND ALNYLAM PHARMACEUTICALS, INC. Dated as of January 11, 2014 TABLE OF CONTENTS (Filed With SEC on May 9, 2014)
- STOCK PURCHASE AGREEMENT by and among ALNYLAMPHARMACEUTICALS, INC., SIRNA THERAPEUTICS, INC., MERCK SHARP & DOHME CORP., and solely for purposes of Sections 3.19, 5.2, 5.6,... (Filed With SEC on May 9, 2014)
- ALNYLAM PHARMACEUTICALS, INC. 8,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on January 16, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 5, 2012)
- ALNYLAM PHARMACEUTICALS, INC. 7,500,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 15, 2012)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Alnylam Tekmira Protiva UBC AlCana Supplemental... (Filed With SEC on June 29, 2011)
- EX-10.8 2004 Employee stock Purchase Plan, as amended (Filed With SEC on March 10, 2008)
- Ex-10.3 Share Purchase Agreement, dated as of July 8, 2007, among Alnylam Europe AG, the Registrant and Roche Pharmaceuticals GmbH (Filed With SEC on November 8, 2007)
- Ex-10.2 Common Stock Purchase Agreement dated as of July 8, 2007 between the Registrant and Roche Finance Ltd (Filed With SEC on November 8, 2007)
- EX-1.1 Underwriting Agreement, dated December 12, 2006 (Filed With SEC on December 13, 2006)
- Ex-10.1 Master Security Agreement (Filed With SEC on April 6, 2006)
- EX-10.2 INVESTOR RIGHTS AGREEMENT (Filed With SEC on September 12, 2005)
- EX-10.1 STOCK PURCHASE AGREEMENT (Filed With SEC on September 12, 2005)
- EX-10.2 - Form of Restricted Stock Agreement (Filed With SEC on July 13, 2005)
- EX-10.1 - Form of Nonstatutory Stock Option Agreement (Filed With SEC on July 13, 2005)
- Ex-10.1 Amendment No. 02 to Loan and Security Agreement (Filed With SEC on June 24, 2005)
- Ex-10.1 Form of Nonstatutory Stock Option Agreement (Filed With SEC on December 28, 2004)
- EX-1.1 Amendment to Underwriting Agreement (Filed With SEC on November 4, 2004)
- EX-10.4 2004 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 10, 2004)
- EX-10.2 2003 EMP, DIRECTOR & CONSULTANT STOCK PLAN (Filed With SEC on May 10, 2004)
